Navigation Links
ForteBio Launches Dip and Read(TM) Immunogenicity Assay Kit for Rapid Detection of Anti-Drug Antibodies
Date:9/16/2009

MENLO PARK, Calif., Sept. 16 /PRNewswire/ -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced today that it has launched the new Dip and Read Immunogenicity Assay Kit for rapid detection of anti-drug antibodies (ADA) for use on the company's Octet(R) platform. The new assay kit provides life science researchers with new levels of throughput, speed and flexibility for measuring immune response to a therapeutic drug, an integral part of drug development.

"Traditional methods for anti-drug antibody detection can be time-consuming, insensitive and labor-intensive, and can result in low throughput," said Christopher Silva, ForteBio's vice president of marketing. "ForteBio's new Dip and Read Immunogenicity Assay Kit overcomes these limitations, providing the needed sensitivity, increased drug tolerance and flexibility to detect both high- and low-affinity ADA. It accomplishes this by leveraging the Octet platform's real-time, label-free detection technology to essentially automate the relevant processing steps and eliminate any plate-washing components."

The Dip and Read Immunogenicity Assay Kit's protocols work across many drug types, including antibodies, proteins and peptides. The assay kit provides biosensors and basic reagents to run two different assay configurations - an enzyme-linked bridging assay and a direct binding assay - for use with human, primate and other animal serum and plasma samples.

ForteBio's Octet system is based on the company's proprietary BioLayer Interferometry (BLI) technology, in which optical biosensors measure multiple interactions in parallel, without the use of detection reagents. The platform includes the Octet QK384 system, which enables 384-well detection, 16-channel simultaneous readout with two plate positions, biosensor regeneration and re-racking, and automation capabilities for increased cost-efficiencies and throughput, as well as faster time to results. The Octet instrumentation software has optional FDA 21 CFR part 11 compliance tools required by GLP laboratories.

About ForteBio, Inc.

ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio's analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai. For more information, visit www.fortebio.com.


'/>"/>
SOURCE ForteBio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ForteBio, Inc. to Present at Thomas Weisel Partners Healthcare Conference 2009
2. ForteBio Launches New Biosensor for Kinetic Analysis and Screening of Human IgG Antibodies
3. Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device
4. Affinion Security Center Launches Benefits to Help Detect and Resolve Medical Identity Theft
5. Autism Support Network Launches Enhanced Features, Adds Thousands of New Members Globally
6. Forterus Inc. Launches Updated, Improved Web Site
7. Loadstar Sensors Launches DI-1000z - Wireless Load Cell Interface
8. Kaiser Permanente Introduces New Ad, Re-launches Two Previous Ads
9. HIPAA.com Launches HIPAA TV
10. Veterinarian Group Launches New Website to Help Pet Owners With Medical Advice and the Best Vet-Approved Products
11. Senior Living Residences Launches Innovative Nutrition Program to Promote Cognitive Health and Lower the Risk of Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 2016 , ... Nordic Naturals announces another breakthrough innovation—Omega Curcumin, ... synergistic combination of omega-3 fatty acids and potent antioxidants contains 1000 mg concentrated ... and 200 mg of N-Acetylcysteine (NAC). , Each nutrient plays a distinct ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... pharmacy industry, today announced that it was chosen as the Pharmaceutical News Provider ... Awards . The awards acknowledge the hard work and dedication of community members ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's top ... months, AudioEducator has lined up some informative training session for the medical coding ... compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... Patient 2016, a powerful cellular therapy software application that helps blood and ... to patients. , Since Transtem’s initial launch, Mediware has continued to enhance core ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Fertility Centers ... at 535 Ocean Ave. Their new Maine Fertility Center provides convenient access to care ... Anne Rainville and her staff at Women’s Wellness Comprehensive Care in Portland,” said Fertility ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ZIONA, Israel , May 4, ... TASE: BVXV) announced today that BiondVax,s CEO, Dr. Ron ... conference in New York City . ... at 10:30am at Pioneers 2016, a conference presented by ... York Palace Hotel. The BiondVax presentation that Dr. ...
(Date:5/4/2016)... , May 4, 2016 ... Jerusalem announced today that it had signed an ... Inc. , developer of novel protein degradation and immunomodulatory ... and commercialization of drug candidates representing first-in-class therapy for ... were not disclosed. The novel technology was ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
Breaking Medicine Technology: